Cover Story
Free
By Paul Goldberg and Matthew Bin Han Ong
FDA may have escaped the devastating cuts in President Trump's first budget proposal, while NIH ended up taking the brunt of its fury.
In Brief
Drugs & Targets
Trending Stories
- In 1971, Chris Lundy had minute odds of survival. He is now the longest living BMT recipient at the Hutch
- Supreme Court removes “Chevron deference,” threatening drug regulation, health coverage, delivery of cancer care
- How Beth Carner went from six weeks left to live with stage 4 colon cancer to complete remission
- Elizabeth Comen joins NYU Langone Health’s Perlmutter Cancer Center
- Murphy, McKay, Nodora, Ballantyne, Stupack named associate directors at UCSD Moores
- The early days of EGFR: Herbst, Haber, Meyerson, Pao, Sequist present at Yale SPORE workshop